Bank of America
ENZY

Bank of America’s Enzymotec Ltd ENZY Stock Holding History

Bank of America’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-400
Closed -$5K – 7579
2017
Q4 		$5K Hold
400
– – ﹤0.01% 6748
2017
Q3 		$5K Sell
400
-100
-20% -$987 ﹤0.01% 6758
2017
Q2 		$4K Buy
500
+100
+25% +$833 ﹤0.01% 6657
2017
Q1 		$4K Hold
400
– – ﹤0.01% 6721
2016
Q4 		$3K Hold
400
– – ﹤0.01% 6814
2016
Q3 		$3K Hold
400
– – ﹤0.01% 6772
2016
Q2 		$3K Hold
400
– – ﹤0.01% 6855
2016
Q1 		$4K Sell
400
-100,000
-100% -$871K ﹤0.01% 6672
2015
Q4 		$984K Hold
100,400
– – ﹤0.01% 4380
2015
Q3 		$909K Hold
100,400
– – ﹤0.01% 4390
2015
Q2 		$838K Buy
100,400
+100,000
+25,000% +$918K ﹤0.01% 4253
2015
Q1 		$3K Hold
400
– – ﹤0.01% 6660
2014
Q4 		$3K Sell
400
-100
-20% -$726 ﹤0.01% 7437
2014
Q3 		$3K Sell
500
-7,465
-94% -$80.5K ﹤0.01% 7722
2014
Q2 		$108K Buy
7,965
+4,278
+116% +$71.8K ﹤0.01% 6078
2014
Q1 		$81K Buy
3,687
+2,975
+418% +$78.9K ﹤0.01% 6133
2013
Q4 		$19K Buy
+712
New +$16.9K ﹤0.01% 7064

Bank of America's ENZY Position: Q1 2018 in Review

Bank of America sold out of Enzymotec Ltd (ENZY) in Q1 2018, closing a stake of 400 shares — an estimated $5K sold.

Bank of America first reported a position in ENZY in Q4 2013 and held it in 17 quarters. The position peaked at $984K in Q4 2015. 0 funds tracked by Wall St. Rank hold ENZY as of Q1 2018.

  • Bank of America reported no remaining Enzymotec Ltd position as of Q1 2018 after selling out during the quarter.
  • Bank of America sold 400 Enzymotec Ltd shares in Q1 2018, an estimated $5K.
  • Bank of America first reported a position in Enzymotec Ltd in Q4 2013 and held it in 17 quarters.
  • Bank of America's Enzymotec Ltd position peaked at $984K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q1 2018.

Based on Bank of America's 13F filing for Q1 2018, filed 15 May 2018.